Does Anemia Have a Potential Effect on Type 2 Hepatorenal Syndrome?

Table 1

Patients CTP groups.

	CTP-A	CTP-B	CTP-C
HRS-2 (n, %)	—	3 (33.3%)	6 (66.7%)
Non-HRS (n, %)	23 (56.1%)	10 (24.4%)	8 (19.5%)
Total (n, %)	23 (46%)	13 (26%)	14 (28%)

HRS-2, hepatorenal syndrome type 2; CTP, Child–Turcotte–Pugh.